Boxer Capital, Llc Esperion Therapeutics, Inc. (ESPR) insider trading activity

Boxer Capital, LLC is > 10% Shareholder of Esperion Therapeutics, Inc.. Currently has a direct ownership of 1.1 Million shares of ESPR, which is worth approximately $1.82 Million. The most recent transaction as insider was on Nov 05, 2018, when has been sold 60,000 shares (Common Stock) at a price of $57.89 per share, resulting in proceeds of $3,473,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.1M

0% 3M change

0% 12M change

Total Value Held $1.82 Million

Boxer Capital, LLC Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Nov 05 2018	SELL Open market or private sale	$3,473,400 $57.89 p/Share	60,000 Reduced 5.17%	1,101,250 Common Stock
Nov 02 2018	SELL Open market or private sale	$2,198,000 $54.95 p/Share	40,000 Reduced 3.33%	1,161,250 Common Stock

Also insider at

MRTX

Mirati Therapeutics, Inc. Healthcare

ITOS

iTeos Therapeutics, Inc. Healthcare

PMVP

PMV Pharmaceuticals, Inc. Healthcare

TNGX

Tango Therapeutics, Inc. Healthcare

TYRA

Tyra Biosciences, Inc. Healthcare

RAIN

Rain Therapeutics Inc. Healthcare

SLDB

Solid Biosciences Inc. Healthcare

> 10% Shareholder

ODTC

Odonate Therapeutics, Inc. Financial Services

> 10% Shareholder

PAND

Pandion Therapeutics, Inc.

> 10% Shareholder

BCL